MICAYLA WEST: Open Payments
NPI 1710642269 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 41 payments from 12 companies in 2025. Trend: 2023 $367 · 2024 $396 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $216 |
| Novo Nordisk Inc | 10 | $183 |
| Amgen Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $48 |
| Astellas Pharma US Inc | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Tris Pharma Inc | 1 | $18 |
Products named: Ozempic, QULIPTA, VRAYLAR, Auvelity, YUPELRI, Veozah, EVENITY, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
